Product Images Losartan Potassium

This is a description of a medication named Losartan Potassium Tablets, USP that comes in a container with 30 tablets. Each tablet contains 100mg of losartan potassium. It is intended for Rx use only, and pharmacists should dispense the patient information leaflet provided separately to each patient. The container must be stored tightly closed at a temperature range of 15° to 30°C (59° to 86°F). The manufacturer is Granules Pharmaceuticals Inc., and the medication is distributed by Unvamish Zone. The usual dosage can be found in the package insert, which is provided in the patient information leaflet. The medication is produced by Granules India Limited, and it is made in India.*

Losartan Potassium Tablets containing 25 mg of losartan potassium, USP. It is Rx only medication. The usual dosage can be found in the package insert. Pharmacists are advised to dispense the patient information sheet along with the medicine to each patient. The tablets are to be stored at 5°C (77°F) with excursions permitted to 16° to 30°C (59°F to 86°F). The container should be kept tightly closed and protected from light. The patient information leaflet is available at https://www.granulespharma.com/products/. Manufactured by Granules India Limited, Hyderabad - 500 081, India. MADE IN INDIA. Distributed by Unvarnished Zone.*

Each tablet contains 50mg of osartan potassium. The tablets should be stored at 25°C (77°F) with excursions permitted to 15° or 30°C. The container should be kept tightly closed and protected from light. The usual dosage should be seen in the package insert. This product is manufactured by Granules India Limited and distributed by Granules Pharmaceuticals Inc. The leaflet is provided separately to each patient.*

This is a table showing the results of a clinical trial comparing the effects of Losartan potassium and a placebo on patients. The table reveals that out of all patients enrolled in the study, 9% experienced some form of medical event. The table shows two groups; one group was given Losartan potassium, while the other group was given a placebo. The group given Losartan potassium had a 16.1% reduction in risk compared to the placebo group. The value of p was 0.022, indicating that the difference between the two groups was statistically significant.*